Clinical Trial Update: Bovine Intestinal Alkaline Phosphatase (bIAP) Modulating Rheumatoid Arthritis [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports completed Phase 1/2 studies evaluating bovine intestinal alkaline phosphatase (bIAP) as a modulator for rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Bovine intestinal alkaline phosphatase (bIAP) (bovine intestinal alkaline phosphatase)

Snippet

Sponsor: Alloksys Life Sciences B.V. | Conditions: Acute Rheumatoid Arthritis | Phase 1, Phase 2 | Status: COMPLETED